Cefepime
These highlights do not include all the information needed to use CEFEPIME FOR INJECTION safely and effectively. See full prescribing information for CEFEPIME FOR INJECTION. CEFEPIME (cefepime hydrochloride) for injection, for intravenous or intramuscular use Initial U.S. Approval: 1996
Approved
Approval ID
dd641c7f-b857-48ff-bd9d-747e0c3cc89f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 10, 2023
Manufacturers
FDA
Apotex Corp.
DUNS: 845263701
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefepime
PRODUCT DETAILS
NDC Product Code60505-6146
Application NumberANDA203704
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateNovember 22, 2021
Generic NameCefepime
INGREDIENTS (2)
CEFEPIME HYDROCHLORIDEActive
Quantity: 1 g in 1 1
Code: I8X1O0607P
Classification: ACTIM
ARGININEInactive
Code: 94ZLA3W45F
Classification: IACT
Cefepime
PRODUCT DETAILS
NDC Product Code60505-6147
Application NumberANDA203704
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateNovember 22, 2021
Generic NameCefepime
INGREDIENTS (2)
CEFEPIME HYDROCHLORIDEActive
Quantity: 2 g in 1 1
Code: I8X1O0607P
Classification: ACTIM
ARGININEInactive
Code: 94ZLA3W45F
Classification: IACT